These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30158936)

  • 1. Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response.
    Rogers D; Vila-Leahey A; Pessôa AC; Oldford S; Marignani PA; Marshall JS
    Front Immunol; 2018; 9():1894. PubMed ID: 30158936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of ranitidine on monocyte responses in the context of solid tumors.
    Vila-Leahey A; Rogers D; Marshall JS
    Oncotarget; 2016 Mar; 7(10):10891-904. PubMed ID: 26863636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice.
    Vila-Leahey A; Oldford SA; Marignani PA; Wang J; Haidl ID; Marshall JS
    Oncoimmunology; 2016 Jul; 5(7):e1151591. PubMed ID: 27622015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Coated Rituximab Induces Highly Cytotoxic Natural Killer Cells From Peripheral Blood Mononuclear Cells
    Niu C; Chen Y; Li M; Zhu S; Zhou L; Xu D; Li Z; Xu J; Li W; Wang Y; Cui J
    Front Immunol; 2021; 12():658562. PubMed ID: 34113342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histaminergic regulation of natural killer cell-mediated clearance of tumour cells in mice.
    Asea A; Hermodsson S; Hellstrand K
    Scand J Immunol; 1996 Jan; 43(1):9-15. PubMed ID: 8560202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy.
    Han Y; Sun F; Zhang X; Wang T; Jiang J; Cai J; Gao Q; Hezam K; Liu Y; Xie J; Wang M; Zhang J
    J Cancer Res Clin Oncol; 2019 May; 145(5):1179-1190. PubMed ID: 30778749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.
    Spallanzani RG; Dalotto-Moreno T; Raffo Iraolagoitia XL; Ziblat A; Domaica CI; Avila DE; Rossi LE; Fuertes MB; Battistone MA; Rabinovich GA; Salatino M; Zwirner NW
    Cancer Immunol Immunother; 2013 Dec; 62(12):1781-95. PubMed ID: 24114144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of histamine in natural killer cell-mediated resistance against tumor cells.
    Hellstrand K; Asea A; Hermodsson S
    J Immunol; 1990 Dec; 145(12):4365-70. PubMed ID: 2147942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β.
    Brownlie D; Doughty-Shenton D; Yh Soong D; Nixon C; O Carragher N; M Carlin L; Kitamura T
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33472858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Numbers of Circulating CD57
    Muntasell A; Servitja S; Cabo M; Bermejo B; Pérez-Buira S; Rojo F; Costa-García M; Arpí O; Moraru M; Serrano L; Tusquets I; Martínez MT; Heredia G; Vera A; Martínez-García M; Soria L; Comerma L; Santana-Hernández S; Eroles P; Rovira A; Vilches C; Lluch A; Albanell J; López-Botet M
    Cancer Immunol Res; 2019 Aug; 7(8):1280-1292. PubMed ID: 31189644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance.
    Hofmann MH; Mani R; Engelhardt H; Impagnatiello MA; Carotta S; Kerenyi M; Lorenzo-Herrero S; Böttcher J; Scharn D; Arnhof H; Zoephel A; Schnitzer R; Gerstberger T; Sanderson MP; Rajgolikar G; Goswami S; Vasu S; Ettmayer P; Gonzalez S; Pearson M; McConnell DB; Kraut N; Muthusamy N; Moll J
    Mol Cancer Ther; 2020 Apr; 19(4):1018-1030. PubMed ID: 32024684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Umbilical Cord Blood-Derived Natural Killer Cells Combined with Bevacizumab for Colorectal Cancer Treatment.
    Xu C; Liu D; Chen Z; Zhuo F; Sun H; Hu J; Li T
    Hum Gene Ther; 2019 Apr; 30(4):459-470. PubMed ID: 29914273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse.
    Ashizawa T; Iizuka A; Nonomura C; Kondou R; Maeda C; Miyata H; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Katano I; Ito M; Akiyama Y
    Clin Cancer Res; 2017 Jan; 23(1):149-158. PubMed ID: 27458246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetyl-D-glucosamine-coated polyamidoamine dendrimer promotes tumor-specific B cell responses via natural killer cell activation.
    Hulikova K; Svoboda J; Benson V; Grobarova V; Fiserova A
    Int Immunopharmacol; 2011 Aug; 11(8):955-61. PubMed ID: 21349367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
    Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
    Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL21 Therapy Combined with PD-1 and Tim-3 Blockade Provides Enhanced NK Cell Antitumor Activity against MHC Class I-Deficient Tumors.
    Seo H; Kim BS; Bae EA; Min BS; Han YD; Shin SJ; Kang CY
    Cancer Immunol Res; 2018 Jun; 6(6):685-695. PubMed ID: 29615398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination treatment with hypofractionated radiotherapy plus IL-2/anti-IL-2 complexes and its theranostic evaluation.
    Jing H; Hettich M; Gaedicke S; Firat E; Bartholomä M; Niedermann G
    J Immunother Cancer; 2019 Feb; 7(1):55. PubMed ID: 30808414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas.
    Rosario M; Liu B; Kong L; Collins LI; Schneider SE; Chen X; Han K; Jeng EK; Rhode PR; Leong JW; Schappe T; Jewell BA; Keppel CR; Shah K; Hess B; Romee R; Piwnica-Worms DR; Cashen AF; Bartlett NL; Wong HC; Fehniger TA
    Clin Cancer Res; 2016 Feb; 22(3):596-608. PubMed ID: 26423796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition.
    Di Modica M; Sfondrini L; Regondi V; Varchetta S; Oliviero B; Mariani G; Bianchi GV; Generali D; Balsari A; Triulzi T; Tagliabue E
    Oncotarget; 2016 Jan; 7(1):255-65. PubMed ID: 26595802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
    Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.